Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

Companies by University of Oxford Department

Archaeology

Specialised archaeological-based IT applications.

Incorporated in June 2001

Origin: Oxford University, Archaeology

Biochemistry

Careers Service

Centre for Cellular and Molecular Physiology

ReOx is a drug discovery company that is building on the primary research of the founding academics to develop novel treatments for disease by controlling the activity of hypoxia inducible factor (HIF).

Incorporated in May 2003

Origin: Oxford University, Centre for Cellular and Molecular Physiology

Chemistry

Specialise in applying state-of-the-art mass spectrometry platforms to characterising intact protein assemblies, often referred to as native mass spectrometry.

Incorporated in March 2016

Origin: Oxford University, Chemistry

Researches, designs and will market diagnostic tests for the measurement of clinical bio markers that reduce healthcare costs and improve patient outcomes.

Incorporated in June 2016

Origin: Oxford University, Chemistry

Catalyst production and processes for upgrading pyrolysis oil to high octane gasoline.

Incorporated in January 2018

Origin: Oxford University, Chemistry

Contact: Jamie Ferguson, RIP

Developing mass photometry - a revolutionary new way to analyse molecules. It enables the accurate mass measurement of single molecules in solution, in their native state and without the need for labels.

Incorporated in June 2018

Origin: Oxford University, Chemistry

Contact: Adam Workman

Increasing Crop Yields to Improve Global Food Security.

Incorporated in March 2018

Origin: Oxford University, Chemistry

Developing novel catalyst process and route to high value internal olefins.

Incorporated in March 2018

Origin: Oxford University, Chemistry

Duchenne Muscular Dystrophy.

Incorporated in November 2013

Origin: Oxford University, Chemistry

Modification of proteins.

Incorporated in May 2002

Origin: Oxford University, Chemistry

Anti-cancer drugs.

Incorporated in January 2002

Origin: Oxford University, Chemistry

Drug Development. Oxford Asymmetry merges with Evotec BioSystems April 2009.

Incorporated in April 1992

Origin: Oxford University, Chemistry

Chemical information management.

Incorporated in August 1989

Origin: Oxford University, Chemistry

Proteomics.

Incorporated in September 1988

Origin: Oxford University, Chemistry

Computer Science

DeepReason.ai offers a Knowledge Graph Management System that can integrate seamlessly with various enterprise, and public, data sources to perform fast and intelligent reasoning

Incorporated in January 2018

Origin: Oxford University, Computer Science

Contact: Adrian Coles

State-of-the-art machine learning technology for autonomous vehicles and traffic modeling applications. Latent Logic was acquired by Waymo in December 2019.

Incorporated in February 2018

Origin: Oxford University, Computer Science

Contact: Adrian Coles

Manufacture of customised shorts using computer vision technology on mobile devices.

Incorporated in October 2020

Origin: Oxford University, Computer Science

Contact: Sandeep Singh

Drug Design.

Incorporated in December 2000

Origin: Oxford University, Computer Science

Computer Sciences

Department of Biochemistry

Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials, crysalins, that are produced through modification of naturally occurring protein building blocks.

Incorporated in June 2007

Origin: Oxford University, Department of Biochemistry

Department of Chemistry

Developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement.

Incorporated in April 2014

Origin: Oxford University, Department of Chemistry

Oxidative Enzymes for the Pulp and Paper Industry.

Incorporated in February 2010

Origin: Oxford University, Department of Chemistry

Oxtox develops medical devices for the detection of specific drugs in the human system.

Incorporated in November 2006

Origin: Oxford University, Department of Chemistry

Oxford Advanced Surfaces develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology.

Incorporated in September 2006

Origin: Oxford University, Department of Chemistry

Oxford Nanopore Technologies is developing and commercialising a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins.

Incorporated in May 2005

Origin: Oxford University, Department of Chemistry

Department of Classics

Develops and manufacturers multispectral digital scanners based upon a patented flatbed scanner design.

Incorporated in September 2011

Origin: Oxford University, Department of Classics

Department of Computer Science

OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.

Incorporated in January 2014

Origin: Oxford University, Department of Computer Science

A revolutionary new approach to indoor positioning that combines data from mobile phone sensors with map information such as floor plans, and wifi “maps” where available, to give highly accurate location information without the need for any further hardware.

Incorporated in December 2015

Origin: Oxford University, Department of Computer Science

SemmleCode is a line of products aimed to help developer teams improve their software quality.

Incorporated in March 2008

Origin: Oxford University, Department of Computer Science

DiffBlue is a world leader in automated test generation. Their products have been developed with industry partners over the last ten years and replace the manual process of writing tests.

Incorporated in March 2016

Origin: Oxford University, Department of Computer Science

Cocotec builds software tools, which harness the power of automated formal verification. Its product, the Coco Platform, comes with a powerful software development environment that enables developers to build their software, automatically verify whether it is correct, and then generate high quality reliable code.

Incorporated in November 2018

Origin: Oxford University, Department of Computer Science

Department of Engineering Science

Deontics is software which guides doctors and patients through the scientific and clinical decision making.

Incorporated in August 2014

Origin: Oxford University, Department of Engineering Science

Offering the most accurate assessment of running biomechanics that modern science is able to provide.

Incorporated in December 2012

Origin: Oxford University, Department of Engineering Science

The OxEML system uses electromagnetic and acoustic waves to create a new class of medical images at a cost comparable to ultrasound.

Incorporated in October 2015

Origin: Oxford University, Department of Engineering Science

Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.

Incorporated in September 2015

Origin: Oxford University, Department of Engineering Science

Developing domestic energy storage capacity and facilitating its operation within the existing power distribution infrastructure.

Incorporated in April 2015

Origin: Oxford University, Department of Engineering Science

Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.

Incorporated in October 2010

Origin: Oxford University, Department of Engineering Science

Oxford Electromagnetic Solutions - smart asset management through underground network visibility.

Incorporated in June 2010

Origin: Oxford University, Department of Engineering Science

YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.

Incorporated in August 2009

Origin: Oxford University, Department of Engineering Science

Navetas is a UK based technology company delivering cloud-based energy monitoring and smart data analytics for the connected home.

Incorporated in November 2008

Origin: Oxford University, Department of Engineering Science

Aurox was established to research, develop, manufacture and commercially exploit products in the field of confocal microscopy and automated pathology slide scanners.

Incorporated in July 2006

Origin: Oxford University, Department of Engineering Science

Particle Therapeutics is a drug delivery company developing innovative particle formulation and drug delivery technologies to improve the efficacy and administration of a range of pharmaceuticals.

Incorporated in June 2006

Origin: Oxford University, Department of Engineering Science

Department of Inorganic Chemistry

Velocys, previously Oxford Catalysts, produces speciality catalysts for the generation of clean fuels, from both conventional fossil fuels and renewable sources such as biomass.

Incorporated in December 2005

Origin: Oxford University, Department of Inorganic Chemistry

Department of Materials

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Incorporated in April 2014

Origin: Oxford University, Department of Materials

Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.

Incorporated in October 2011

Origin: Oxford University, Department of Materials

Tissue expander solutions for the primary use in reconstructive and dental surgery.

Incorporated in July 2011

Origin: Oxford University, Department of Materials

Department of Oncology

Department of Organic Chemistry

Robust, networked sensors for oilfield machinery, drilling and metering.

Incorporated in June 2005

Origin: Oxford University, Department of Organic Chemistry

Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile.

Incorporated in February 2003

Origin: Oxford University, Department of Organic Chemistry

Department of Pathology

Oxford BioDynamics offers a novel and revolutionary biomarker discovery platform technology in the diagnostics field of aberrant gene expression.

Incorporated in June 2007

Origin: Oxford University, Department of Pathology

BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.

Incorporated in November 2002

Origin: Oxford University, Department of Pathology

Department of Pharmacology

G-Nostics has identified SNPs that have highly predictive associations with nicotine addiction and therefore tobacco consumption. These SNPs provide a method to help individuals decide which specific smoking cessation methods are most effective for them, offering personalised treatment to the 'smoker' which significantly increases their chances of quitting.

Incorporated in June 2004

Origin: Oxford University, Department of Pharmacology

Department of Physics

Oxford PV are developing new photovoltaic cells that will provide a sustainable solar energy source.

Incorporated in November 2010

Origin: Oxford University, Department of Physics

Department of Physiology, Anatomy and Genetics

TdeltaS is committed to developing science-based proprietary products that sit at the interface of food and pharmaceuticals - nutraceuticals - and offer real improvement in human physical and mental performance.

Incorporated in March 2006

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
conditions.

Incorporated in December 2018

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Contact: Adam Workman

Department of Surgical Sciences

A biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.

Incorporated in November 2010

Origin: Oxford University, Department of Surgical Sciences

Department of Zoology

Animal Dynamics marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.

Incorporated in April 2015

Origin: Oxford University, Department of Zoology

DPAG

Therapeutics biotech company developing proprietary drug delivery platform technology.

Incorporated in March 2018

Origin: Oxford University, DPAG

Engineering

Proxisense specialise in advanced sensors, diagnostics and optimisation systems to prevent downtime & equipment failure. They improve performance & efficiency of complex rotating equipment.

Incorporated in October 2016

Origin: Oxford University, Engineering

AR/AV platform technology for software industry. 6D.ai was aquired by Niantic in March 2020.

Incorporated in October 2017

Origin: Oxford University, Engineering

Contact: Mark Mann

Development of asthma monitoring system

Incorporated in November 2017

Origin: Oxford University, Engineering

Development and application of bacterial biosensors for detection and quantification of environmental contamination, including organics and metals, on-site and in real-time.

Incorporated in August 2018

Origin: Oxford University, Engineering

Contact: Andy Robertson

A software development company that produce clinical trial data. In 2005 Third Phase Ltd merged with the Cmed Group Ltd. Third Phase Limited Merges with Cmed Group October 2005.

Incorporated in January 2000

Origin: Oxford University, Engineering

A lean spin-out, social enterprise focusing on developing a fast rapid COVID-19 test. Joint Oxford University and OSCAR company.

Incorporated in June 2020

Origin: Oxford University, Engineering

Contact: Jane Jin

Focused on creating novel biosensors for food safety testing.

Incorporated in August 2020

Origin: Oxford University, Engineering

Open Clinical aims to create a publicly available resource to benefit clinicians and patients.

Incorporated in August 2020

Origin: Oxford University, Engineering

OxVent Limited is a joint-venture social enterprise that will license the OxVent ventilator design for international deployment in Covid19 and beyond, and provide consultancy on its testing, regulatory approval and manufacturing.

Incorporated in September 2020

Origin: Oxford University, Engineering

Engineering/ Pathology

Geography, Maths, Computer Sciences, Engineering

Maritime trade and transport simulation.

Incorporated in February 2017

Origin: Oxford University, Geography, Maths, Computer Sciences, Engineering

Humanities

Computer game language development software.

Incorporated in April 2000

Origin: Oxford University, Humanities

Institute of Biomedical Engineering

OxSonics provide economic and scalable life-changing treatments to solid tumour cancer patients.

Incorporated in January 2014

Origin: Oxford University, Institute of Biomedical Engineering

Revolutionary healthcare technology that measures medical vital signs without physical contact.

Incorporated in August 2012

Origin: Oxford University, Institute of Biomedical Engineering

Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.

Incorporated in July 2012

Origin: Oxford University, Institute of Biomedical Engineering

Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.

Incorporated in July 2009

Origin: Oxford University, Institute of Biomedical Engineering

International Development

A not for profit company providing a solution and accreditation to businesses that work to bring their workforce out of multidimensional poverty

Incorporated in November 2018

Origin: Oxford University, International Development

Contact: Mark Mann

Campus supports sustainable, integrated and interuniversity learning opportunities, reinvesting profits in scholarships for students and/or building capacity in local heritage structures.

Incorporated in October 2020

Origin: Oxford University, International Development

Jenner Institute

Malaria vaccine development.

Incorporated in September 2019

Origin: Oxford University, Jenner Institute

Linguistics

Ludwig Institute for Cancer Research

DNA methylation detection using this TAPS technology. Base Genomics was acquired by Exact Sciences in October 2020.

Incorporated in June 2020

Origin: Oxford University, Ludwig Institute for Cancer Research

Materials

Automotive components.

Incorporated in April 2001

Origin: Oxford University, Materials

Materials and UCL

Mathematical Institute

Developing international trade and transport simulators, using mathematical models and machine learning.

Incorporated in November 2020

Origin: Oxford University, Mathematical Institute

Contact: Adrian Coles

Maths

Parallel hardware/software design.

Incorporated in June 1999

Origin: Oxford University, Maths

NDORMS & NDPH

Software enabled system for orthopaedic care pathway management, implant safety monitoring and patient reported outcome delivery.

Incorporated in March 2017

Origin: Oxford University, NDORMS & NDPH

Neuroscience

EvOx Therapeutics harnesses the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.

Incorporated in April 2016

Origin: Oxford University, Neuroscience

The OxSight ‘SmartSpecs’ help sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

Incorporated in June 2016

Origin: Oxford University, Neuroscience

Nuffield Department of Clinical Medicine

Oxford Immunotec is a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. In 2021, Oxford Immunotec was acquired by PerkinElmer.

Incorporated in October 2002

Origin: Oxford University, Nuffield Department of Clinical Medicine

Nuffield Department of Clinical Neurosciences

A private biopharmaceutical company focused on the development of therapies for retinal dystrophies. NightStar Therapeutics was acquired by Biogen in June 2019.

Incorporated in January 2014

Origin: Oxford University, Nuffield Department of Clinical Neurosciences

Nuffield Department of Surgical Sciences

Developing a brain implant to treat a variety of diseases.

Incorporated in October 2018

Origin: Oxford University, Nuffield Department of Surgical Sciences

Nuffield Dept of Women's and Reproductive Health

Oxford Digital Innovation encompasses three different products. Two of them are online health records platform which aim to integrate NHS data (Zygote – IVF platform – and Simba – maternity platform). The 3rd platform is a virtual hospital which is aimed at scheduling appointments for patients and enable online consultations in specific specialisations, starting with eye care, skin care, pathology and dental medicine.

Incorporated in August 2020

Origin: Oxford University, Nuffield Dept of Women's and Reproductive Health

Method for ranking/selecting mitochondrial neoantigens for targeted cell therapy.

Incorporated in November 2020

Origin: Oxford University, Nuffield Dept of Women's and Reproductive Health

Contact: Richard Auburn

Oncology

Research and experimental development on biotechnology.

Incorporated in July 2020

Origin: Oxford University, Oncology

Organic Chemistry

Glycosolation technology.

Incorporated in August 2002

Origin: Oxford University, Organic Chemistry

Pathology

OxStem Beta will generate novel therapies to stimulate formation of new beta cells in the pancreas
(neogenesis) by targeting pathways that are normally only active during development or following
pancreatic injury.

Incorporated in December 2018

Origin: Oxford University, Pathology

Immunology.

Incorporated in December 2000

Origin: Oxford University, Pathology

Antibiotics.

Incorporated in June 1998

Origin: Oxford University, Pathology

Neurodegenerative diseases.

Incorporated in March 1998

Origin: Oxford University, Pathology

Physical and Theoretical Chemistry

Physics

Oxford Nanoimaging’s microscope, the Nanoimager, is a single-molecule fluorescence microscope.
It is about 30 times smaller and significantly less expensive than current super-resolution microscopes and will be manufactured in the UK.

Incorporated in May 2016

Origin: Oxford University, Physics

Psychiatry

Virtual Reality software to help treat people with severe paranoia by allowing them to face situations that they fear.

Incorporated in December 2016

Origin: Oxford University, Psychiatry

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Incorporated in May 2019

Origin: Oxford University, Psychiatry

Radcliffe department of medicine

Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.

Incorporated in July 2015

Origin: Oxford University, Radcliffe Department of Medicine

Software development for a novel biomarker to detect coronary heart disease.

Incorporated in July 2018

Origin: Oxford University, Radcliffe department of medicine

Contact: James Groves

Science and Technology Facilities Council

Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.

Incorporated in January 2011

Origin: Oxford University, Science and Technology Facilities Council

The Oxford Internet Institute

Expertise and knowledge regarding data privacy, ethics, data security and public policy in connection with technology use.

Incorporated in August 2020

Origin: Oxford University, The Oxford Internet Institute

Tropical Medicine

Aim is to accelerate and streamline research through an innovative digital platform for knowledge sharing.

Incorporated in July 2020

Origin: Oxford University, Tropical Medicine

Weatherall Institute of Molecular Medicine

Wellcome Trust Centre for Human Genetics

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.

Incorporated in March 2014

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs. Surface Therapeutics was acquired by Serentis Inc in September 2007.

Incorporated in November 2004

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

A biotherapeutics company, established to exploit the work in Viral Hepatitis undertaken at Imperial College, London and at Oxford University through the Wellcome Trust Centre for Human Genetics.

Incorporated in July 2003

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Zoology

Ready to get in touch?

Contact Us
© Oxford University Innovation